History & Overview Annual Report Center News Community Affairs Code of Conduct
Make a Gift Cycle for Survival Fred's Team Yankees Universe Fund Thomas Blake Sr. Memorial Research Fund Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck CELEBRATIONS
Press Releases In the News Information for Journalists News@MSKCC
Manhattan New Jersey Long Island Westchester
Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days IS Careers Job Search & Apply Online
Making an Appointment
Prostate Cancer
Prediction Tool
Prostate Cancer Prediction Tool
Our Prostate Nomogram helps physicians and patients decide which treatment will result in the greatest benefit

Our prostate nomogram is designed to help physicians and patients decide which treatment approaches will result in the greatest benefit. It is recommended that patients using the tool consult with a physician or other professional healthcare provider prior to making any treatment decisions.


Clicking a link below will scroll the
page down to the relevant section

What This Tool Predicts

Supporting Publications
Supporting Publications
Visit PubMed to view the journal articles that support these nomograms

A combination of disease factors including stage of the cancer, prostate specific antigen (PSA) level, biopsy pathology, use of hormone therapy, and radiation dosage have been incorporated into the nomograms.

  • For men who have received no primary treatment, this nomogram calculates the statistical probability of a cancer remaining progression-free after receiving one of three treatment options: prostatectomy, external beam radiation therapy, and brachytherapy.

  • For men who have been treated with a prostatectomy, this tool predicts probability of survival.

  • For men who have experienced a recurrence of their prostate cancer after being treated with a prostatectomy, this tool predicts treatment success for salvage radiation therapy (SRT).

  • For men who have received either prostatectomy or radiation therapy and are considering hormone refractory treatment (HRT), this tool predicts one- and two-year survival after HRT.

  • This tool can be used to predict the probability and time to the development of metastatic disease.

  • This tool calculates prostate volume, which is used to interpret PSA results.

Who Can Use This Tool

  • For Patients Who Have Not Been Treated

    The tool is designed to be used by patients who have had a biopsy of the prostate confirming the presence of cancer. The biopsy must have had a Gleason grade assigned to it. In addition, patients will need other clinical data.

    The tool can also be used by patients who are considering hormone refractory therapy.

    The tool cannot be used by patients whose prostate cancer is believed to have spread to other parts of the body, such as bones or lymph nodes.

  • For Patients Who Have Been or Are Receiving Treatment

    Portions of this tool can be used by patients who have had a radical prostatectomy surgery or received radiation therapy to treat prostate cancer.

What Information Will I Need?

Because the prostate nomogram is designed to be used by patients in conjunction with their doctors, men with prostate cancer may not have all the necessay clinical data to use the nomogram. The What Information Will I Need? page describes what clinical data is required to use each section of our prostate cancer nomogram -- Pre-Treatment, Post-Radical Prostatectomy, Salvage Radiation Therapy, and Hormone Refractory. Included in this page are links to downloadable worksheets, which can be printed and reviewed at your next doctor's appointment.

How to Use This Tool

The prostate nomogram requires no special software downloads and can be used on any standard Web browser. Open calculator to use the prostate nomogram.

Contact Us

If you have questions or comments, please do not hesitate to contact us at publicaffairs@mskcc.org.

Special Note

The results produced by this prediction tool should be discussed with your physician before making any treatment decisions.


Last Updated: Feb. 13, 2009
Bookmark and SharePrintEmail This Page